Abstract
Abdominal aortic aneurysm (AAA) is a multifactorial disease with a significant genetic component. Epidemiological studies have identified family history of AAA as a risk factor for both aneurysm development and rupture, making it an important consideration for targeted ultrasound screening of elderly patients and their family members. Ongoing research into the genetics of AAA is focused on identifying risk factor genes for both familial and sporadic aneurysms through the use of linkage analyses and genetic association studies, although no causative mutations have yet been identified. Additionally, micro-array expression profiling and animal models of aneurysms are being used to identify genes and pathways for the design of novel therapeutics. These approaches promise to deliver a better understanding of aneurysms at the molecular level leading to improved screening and treatment.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Alcorn HG, Wolfson SK, Jr., Sutton-Tyrrell K, Kuller LH, O'Leary D. Risk factors for abdominal aortic aneurysms in older adults enrolled in The Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 1996;16(8):963–970.
WISQARS Leading Causes of Death Reports, 1999–2004. 2007. (Accessed October 15, 2007, at http://webappa.cdc.gov/sasweb/ncipc/leadcaus10.html.)
Johansen K, Kohler TR, Nicholls SC, Zierler RE, Clowes AW, Kazmers A. Ruptured abdominal aortic aneurysm: the Harborview experience. J Vasc Surg 1991;13(2):240–245.
Krupski WC, Rutherford RB. Update on open repair of abdominal aortic aneurysms: the challenges for endovascular repair. J Am Coll Surg 2004;199(6):946–960.
Lederle FA, Johnson GR, Wilson SE, et al. The aneurysm detection and management study screening program: validation cohort and final results. Aneurysm Detection and Management Veterans Affairs Cooperative Study Investigators. Arch Intern Med 2000;160(10):1425–1430.
Kuivaniemi H, Tromp G, Prockop DJ. Genetic causes of aortic aneurysms. Unlearning at least part of what the textbooks say. J Clin Invest 1991;88(5): 1441–1444.
Bengtsson H, Sonesson B, Bergqvist D. Incidence and prevalence of abdominal aortic aneurysms, estimated by necropsy studies and population screening by ultrasound. Ann N Y Acad Sci 1996;800:1–24.
Kuivaniemi H, Marshall A, Ganguly A, Chu ML, Abbott WM, Tromp G. Fibulin-2 exhibits high degree of variability, but no structural changes concordant with abdominal aortic aneurysms. Eur J Hum Genet 1998;6(6):642–646.
Kuivaniemi H, Tromp G. Search for the aneurysm susceptibility gene(s). In: Keen RR, Dobrin PB, eds. Development of Aneurysms. Georgetown: Landes Bioscience; 2000:219–233.
Norrgard O, Rais O, Angquist KA. Familial occurrence of abdominal aortic aneu-rysms. Surgery 1984;95(6):650–656.
Johansen K, Koepsell T. Familial tendency for abdominal aortic aneurysms. JAMA 1986;256(14):1934–1936.
Powell JT, Greenhalgh RM. Multifactorial inheritance of abdominal aortic aneurysm. Eur J Vasc Surg 1987;1(1):29–31.
Johnston KW, Scobie TK. Multicenter prospective study of nonruptured abdominal aortic aneurysms. I. Population and operative management. J Vasc Surg 1988;7(1):69–81.
Cole CW, Barber GG, Bouchard AG, et al. Abdominal aortic aneurysm: consequences of a positive family history. Can J Surg 1989;32(2):117–120.
Darling RC, 3rd, Brewster DC, Darling RC, et al. Are familial abdominal aortic aneurysms different? J Vasc Surg 1989;10(1):39–43.
Majumder PP, St Jean PL, Ferrell RE, Webster MW, Steed DL. On the inheritance of abdominal aortic aneurysm. Am J Hum Genet 1991;48(1):164–170.
Verloes A, Sakalihasan N, Koulischer L, Limet R. Aneurysms of the abdominal aorta: familial and genetic aspects in three hundred thirteen pedigrees. J Vasc Surg 1995;21(4):646–655.
Lederle FA, Johnson GR, Wilson SE, et al. Prevalence and associations of abdominal aortic aneurysm detected through screening. Aneurysm Detection and Management (ADAM) Veterans Affairs Cooperative Study Group. Ann Intern Med 1997;126(6):441–449.
Lawrence PF, Wallis C, Dobrin PB, et al. Peripheral aneurysms and arteriomegaly: is there a familial pattern? J Vasc Surg 1998;28(4):599–605.
Salkowski A, Greb A, Al-Aouar R, et al. Familial incidence of abdominal aortic aneurysms. J Genet Couns 1999;8:407.
Rossaak JI, Hill TM, Jones GT, Phillips LV, Harris EL, van Rij AM. Familial abdominal aortic aneurysms in the Otago region of New Zealand. Cardiovasc Surg 2001;9(3):241–248.
Bengtsson H, Norrgard O, Angquist KA, Ekberg O, Oberg L, Bergqvist D. Ultrasonographic screening of the abdominal aorta among siblings of patients with abdominal aortic aneurysms. Br J Surg 1989;76(6):589–591.
Collin J, Walton J. Is abdominal aortic aneurysm familial? BMJ 1989; 299(6697):493.
Webster MW, St Jean PL, Steed DL, Ferrell RE, Majumder PP. Abdominal aortic aneurysm: results of a family study. J Vasc Surg 1991;13(3):366–372.
Adamson J, Powell JT, Greenhalgh RM. Selection for screening for familial aortic aneurysms. Br J Surg 1992;79(9):897–898.
Bengtsson H, Sonesson B, Lanne T, et al. Prevalence of abdominal aortic aneurysm in the offspring of patients dying from aneurysm rupture. Br J Surg 1992;79(11):1142–1143.
van der Lugt A, Kranendonk SE, Baars AM. Screening for familial occurrence of abdominal aortic aneurysm. Ned Tijdschr Geneeskd 1992;136(39):1910–1913.
Adams DC, Tulloh BR, Galloway SW, Shaw E, Tulloh AJ, Poskitt KR. Familial abdominal aortic aneurysm: prevalence and implications for screening. Eur J Vasc Surg 1993;7(6):709–712.
Moher D, Cole CW, Hill GB. Definition and management of abdominal aortic aneurysms: results from a Canadian survey. Can J Surg 1994;37(1):29–32.
Fitzgerald P, Ramsbottom D, Burke P, et al. Abdominal aortic aneurysm in the Irish population: a familial screening study. Br J Surg 1995;82(4):483–486.
Larcos G, Gruenewald SM, Fletcher JP. Ultrasound screening of families with abdominal aortic aneurysm. Australas Radiol 1995;39(3):254–256.
Baird PA, Sadovnick AD, Yee IM, Cole CW, Cole L. Sibling risks of abdominal aortic aneurysm. Lancet 1995;346(8975):601–604.
Jaakkola P, Kuivaniemi H, Partanen K, Tromp G, Liljestrom B, Ryynanen M. Familial abdominal aortic aneurysms: screening of 71 families. Eur J Surg 1996;162(8):611–617.
van der Graaf Y, Akkersdijk GJ, Hak E, Godaert GL, Eikelboom BC. Results of aortic screening in the brothers of patients who had elective aortic aneurysm repair. Br J Surg 1998;85(6):778–780.
Salo JA, Soisalon-Soininen S, Bondestam S, Mattila PS. Familial occurrence of abdominal aortic aneurysm. Ann Intern Med 1999;130(8):637–642.
Frydman G, Walker PJ, Summers K, et al. The value of screening in siblings of patients with abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 2003;26(4): 396–400.
Ogata T, MacKean GL, Cole CW, et al. The lifetime prevalence of abdominal aortic aneurysms among siblings of aneurysm patients is eightfold higher than among siblings of spouses: an analysis of 187 aneurysm families in Nova Scotia, Canada. J Vasc Surg 2005;42(5):891–897.
Badger SA, O'Donnell ME, Boyd CS, et al. The low prevalence of abdominal aortic aneurysm in relatives in northern Ireland. Eur J Vasc Endovasc Surg 2007;34(2):163–168.
Kuivaniemi H, Shibamura H, Arthur C, et al. Familial abdominal aortic aneurysms: collection of 233 multiplex families. J Vasc Surg 2003;37(2):340–345.
Thompson MW, E. MR, F. WH. Genetics in Medicine. 5th ed. Philadelphia: W.B. Saunders Company; Harcourt Brace Jovanovisch, Inc.; 1991.
Norman PE, Powell JT. Abdominal aortic aneurysm: the prognosis in women is worse than in men. Circulation 2007;115(22):2865–2869.
Katz DJ, Stanley JC, Zelenock GB. Operative mortality rates for intact and ruptured abdominal aortic aneurysms in Michigan: an eleven-year statewide experience. J Vasc Surg 1994;19(5):804–815.
Katz DJ, Stanley JC, Zelenock GB. Gender differences in abdominal aortic aneu-rysm prevalence, treatment, and outcome. J Vasc Surg 1997;25(3):561–568.
Limet R. Familial risk of abdominal aortic aneurysm and its consequences for organization of selective detection. J Mal Vasc 1995;20(4):285–287.
Nakka P, Chu J, Roake J, Lewis D. Variability in counselling patients regarding the hereditary nature of abdominal aortic aneurysm (AAA). Lack of evidence or resources? N Z Med J 2007;120(1251):U2460.
Harper PS. Practical Genetic Counseling. 6th ed. London: Arnold Publishers; 2004.
Brewster DC, Cronenwett JL, Hallett JW, Jr., Johnston KW, Krupski WC, Matsumura JS. Guidelines for the treatment of abdominal aortic aneurysms. Report of a subcommittee of the Joint Council of the American Association for Vascular Surgery and Society for Vascular Surgery. J Vasc Surg 2003;37(5):1106–1117.
Vande Geest JP, Wang DH, Wisniewski SR, Makaroun MS, Vorp DA. Towards a noninvasive method for determination of patient-specific wall strength distribution in abdominal aortic aneurysms. Ann Biomed Eng 2006;34(7):1098–1106.
Screening for Abdominal Aortic Aneurysm, Topic Page. US Preventative Services Task Force. Agency for Healthcare Research and Quality, 2005. (Accessed November 7th, 2007, at http://www.ahrq.gov/clinic/uspstf/uspsaneu.htm.)
Fleming C, Whitlock EP, Beil TL, Lederle FA. Screening for abdominal aortic aneurysm: a best-evidence systematic review for the US Preventive Services Task Force. Ann Intern Med 2005;142(3):203–211.
Kent KC, Zwolak RM, Jaff MR, et al. Screening for abdominal aortic aneurysm: a consensus statement. J Vasc Surg 2004;39(1):267–269.
Le Hello C, Koskas F, Cluzel P, et al. French women from multiplex abdominal aortic aneurysm families should be screened. Ann Surg 2005;242(5):739–744.
Olson JM, Witte JS, Elston RC. Genetic mapping of complex traits. Stat Med 1999;18(21):2961–2981.
Shibamura H, Olson JM, Van Vlijmen-Van Keulen CJ, et al. Genome scan for familial abdominal aortic aneurysm using sex and family history as covariates suggests genetic heterogeneity and identifies linkage to chromosome 19q13. Circulation 2004;109(17):2103–2108.
van Vlijmen-Van Keulen CJ, Rauwerda JA, Pals G. Genome-wide linkage in three Dutch families maps a locus for abdominal aortic aneurysms to chromosome 19q13.3. Eur J Vasc Endovasc Surg 2005;30(1):29–35.
Online Mendelian Inheritance in Man, OMIM (TM). (Accessed November 13, 2007, at http://www.ncbi.nlm.nih.gov/omim/.)
Pannu H, Avidan N, Tran-Fadulu V, Milewicz DM. Genetic basis of thoracic aortic aneurysms and dissections: potential relevance to abdominal aortic aneurysms. Ann N Y Acad Sci 2006;1085:242–255.
Beckman JA. Aortic aneurysms: pathophysiology, epidemiology, and prognosis. In: Creager MA, Dzau VJ, Loscalzo J, eds. Vascular Medicine. Philadelphia: Saunders Elsevier, Inc.; 2006:543–559.
Elston RC. Linkage and association. Genet Epidemiol 1998;15(6):565–576.
Devlin B, Roeder K. Genomic control for association studies. Biometrics 1999;55(4):997–1004.
Bamshad MJ, Wooding S, Watkins WS, Ostler CT, Batzer MA, Jorde LB. Human population genetic structure and inference of group membership. Am J Hum Genet 2003;72(3):578–589.
Chanock SJ, Manolio T, Boehnke M, et al. Replicating genotype-phenotype associations. Nature 2007;447(7145):655–660.
Powell JT, Bashir A, Dawson S, et al. Genetic variation on chromosome 16 is associated with abdominal aortic aneurysm. Clin Sci (Lond) 1990;78(1):13–16.
St Jean PL, Zhang XC, Hart BK, et al. Characterization of a dinucleotide repeat in the 92 kDa type IV collagenase gene (CLG4B), localization of CLG4B to chromosome 20 and the role of CLG4B in aortic aneurysmal disease. Ann Hum Genet 1995;59(Pt 1):17–24.
Hamano K, Ohishi M, Ueda M, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is not a risk factor predisposing to abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 1999;18(2):158–161.
Wang X, Tromp G, Cole CW, et al. Analysis of coding sequences for tissue inhibitor of metalloproteinases 1 (TIMP1) and 2 (TIMP2) in patients with aneurysms. Matrix Biol 1999;18(2):121–124.
Yoon S, Tromp G, Vongpunsawad S, Ronkainen A, Juvonen T, Kuivaniemi H. Genetic analysis of MMP3, MMP9, and PAI-1 in Finnish patients with abdominal aortic or intracranial aneurysms. Biochem Biophys Res Commun 1999; 265(2):563–568.
Brunelli T, Prisco D, Fedi S, et al. High prevalence of mild hyperhomocysteinemia in patients with abdominal aortic aneurysm. J Vasc Surg 2000;32(3):531–536.
Kotani K, Shimomura T, Murakami F, et al. Allele frequency of human endothelial nitric oxide synthase gene polymorphism in abdominal aortic aneurysm. Intern Med 2000;39(7):537–539.
Rossaak JI, Van Rij AM, Jones GT, Harris EL. Association of the 4G/5G polymorphism in the promoter region of plasminogen activator inhibitor-1 with abdominal aortic aneurysms. J Vasc Surg 2000;31(5):1026–1032.
Pola R, Gaetani E, Santoliquido A, et al. Abdominal aortic aneurysm in normoten-sive patients: association with angiotensin-converting enzyme gene polymorphism. Eur J Vasc Endovasc Surg 2001;21(5):445–449.
Schillinger M, Exner M, Mlekusch W, et al. Heme oxygenase-1 gene promoter polymorphism is associated with abdominal aortic aneurysm. Thromb Res 2002;106(2):131–136.
Unno N, Nakamura T, Mitsuoka H, et al. Association of a G994 T missense mutation in the plasma platelet-activating factor acetylhydrolase gene with risk of abdominal aortic aneurysm in Japanese. Ann Surg 2002;235(2):297–302.
Jones GT, Phillips VL, Harris EL, Rossaak JI, van Rij AM. Functional matrix metalloproteinase-9 polymorphism (C-1562T) associated with abdominal aortic aneurysm. J Vasc Surg 2003;38(6):1363–1367.
Bown MJ, Burton PR, Horsburgh T, Nicholson ML, Bell PR, Sayers RD. The role of cytokine gene polymorphisms in the pathogenesis of abdominal aortic aneu-rysms: a case-control study. J Vasc Surg 2003;37(5):999–1005.
Ghilardi G, Biondi ML, Battaglioli L, Zambon A, Guagnellini E, Scorza R. Genetic risk factor characterizes abdominal aortic aneurysm from arterial occlusive disease in human beings: CCR5 Delta 32 deletion. J Vasc Surg 2004;40(5):995–1000.
Massart F, Marini F, Menegato A, et al. Allelic genes involved in artery compliance and susceptibility to sporadic abdominal aortic aneurysm. J Steroid Biochem Mol Biol 2004;92(5):413–418.
Fatini C, Pratesi G, Sofi F, et al. ACE DD genotype: a predisposing factor for abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 2005;29(3):227–232.
Fatini C, Sofi F, Sticchi E, et al. eNOS G894T polymorphism as a mild predisposing factor for abdominal aortic aneurysm. J Vasc Surg 2005;42(3):415–419.
Ogata T, Shibamura H, Tromp G, et al. Genetic analysis of polymorphisms in biologically relevant candidate genes in patients with abdominal aortic aneurysms. J Vasc Surg 2005;41(6):1036–1042.
Schulz V, Hendig D, Schillinger M, et al. Analysis of sequence variations in the ABCC6 gene among patients with abdominal aortic aneurysm and pseudoxan-thoma elasticum. J Vasc Res 2005;42(5):424–432.
Golledge J, Muller J, Daugherty A, Norman P. Abdominal aortic aneurysm: pathogenesis and implications for management. Arterioscler Thromb Vasc Biol 2006;26(12):2605–2613.
Armani C, Curcio M, Barsotti MC, et al. Polymorphic analysis of the matrix metalloproteinase-9 gene and susceptibility to sporadic abdominal aortic aneurysm. Biomed Pharmacother 2007;61(5):268–271.
Bown MJ, Lloyd GM, Sandford RM, et al. The interleukin-10–1082 “ A ” allele and abdominal aortic aneurysms. J Vasc Surg 2007;46(4):687–693.
Smallwood L, Allcock R, van Bockxmeer F, et-al. Polymorphisms of the interleukin-6 gene promoter and abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 2007.
Helgadottir A, Thorleifsson G, Magnusson KP, et al. The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat Genet 2008;40(2):217–224.
Jones GT, Thompson AR, van Bockxmeer FM, et al. Angiotensin II type 1 receptor 1166C polymorphism is associated with abdominal aortic aneurysm in three independent cohorts. Arterioscler Thromb Vasc Biol 2008;28(4):764–770.
Gotting C, Prante C, Schillinger M, et al. Xylosyltransferase I variants and their impact on abdominal aortic aneurysms. Clin Chim Acta 2008;391(1–2):41–45.
Norrgard O, Cedergren B, Angquist KA, Beckman L. Blood groups and HLA antigens in patients with abdominal aortic aneurysms. Hum Hered 1984;34(1):9–13.
Rasmussen TE, Hallett JW, Jr., Metzger RL, et al. Genetic risk factors in inflammatory abdominal aortic aneurysms: polymorphic residue 70 in the HLA-DR B1 gene as a key genetic element. J Vasc Surg 1997;25(2):356–364.
Hirose H, Takagi M, Miyagawa N, et al. Genetic risk factor for abdominal aortic aneurysm: HLA-DR2(15), a Japanese study. J Vasc Surg 1998;27(3):500–503.
Hirose H, Tilson MD. Negative genetic risk factor for abdominal aortic aneurysm: HLA-DQ3, a Japanese study. J Vasc Surg 1999;30(5):959–960.
Rasmussen TE, Hallett JW, Jr., Schulte S, Harmsen WS, O'Fallon WM, Weyand CM. Genetic similarity in inflammatory and degenerative abdominal aortic aneu-rysms: a study of human leukocyte antigen class II disease risk genes. J Vasc Surg 2001;34(1):84–89.
Rasmussen TE, Hallett JW, Jr., Tazelaar HD, et al. Human leukocyte antigen class II immune response genes, female gender, and cigarette smoking as risk and modulating factors in abdominal aortic aneurysms. J Vasc Surg 2002;35(5):988–993.
Ogata T, Gregoire L, Goddard KA, et al. Evidence for association between the HLA-DQA locus and abdominal aortic aneurysms in the Belgian population: a case control study. BMC Med Genet 2006;7:67.
Badger SA, Soong CV, O'Donnell ME, Middleton D. The role of human leukocyte antigen genes in the formation of abdominal aortic aneurysms. J Vasc Surg 2007;45(3):475–480.
Ashburner M, Ball CA, Blake JA, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000;25(1):25–29.
Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000;28(1):27–30.
Allison DB, Cui X, Page GP, Sabripour M. Microarray data analysis: from disarray to consolidation and consensus. Nat Rev Genet 2006;7(1):55–65.
Tung WS, Lee JK, Thompson RW. Simultaneous analysis of 1176 gene products in normal human aorta and abdominal aortic aneurysms using a membrane-based complementary DNA expression array. J Vasc Surg 2001;34(1):143–150.
Armstrong PJ, Johanning JM, Calton WC, Jr., et al. Differential gene expression in human abdominal aorta: aneurysmal versus occlusive disease. J Vasc Surg 2002;35(2):346–355.
Absi TS, Sundt TM, 3rd, Tung WS, et al. Altered patterns of gene expression distinguishing ascending aortic aneurysms from abdominal aortic aneurysms: complementary DNA expression profiling in the molecular characterization of aortic disease. J Thorac Cardiovasc Surg 2003;126(2):344–357.
Yamagishi M, Higashikata T, Ishibashi-Ueda H, et al. Sustained upregula-tion of inflammatory chemokine and its receptor in aneurysmal and occlusive atherosclerotic disease: results form tissue analysis with cDNA macroarray and real-time reverse transcriptional polymerase chain reaction methods. Circ J 2005;69(12):1490–1495.
Lenk GM, Tromp G, Weinsheimer S, Gatalica Z, Berguer R, Kuivaniemi H. Whole genome expression profiling reveals a significant role for immune function in human abdominal aortic aneurysms. BMC Genomics 2007;8:237.
Daugherty A, Cassis LA. Mouse models of abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2004;24(3):429–434.
Thompson RW, Curci JA, Ennis TL, Mao D, Pagano MB, Pham CT. Pathophysiology of abdominal aortic aneurysms: insights from the elastase-induced model in mice with different genetic backgrounds. Ann N Y Acad Sci 2006; 1085:59–73.
Shimizu K, Shichiri M, Libby P, Lee RT, Mitchell RN. Th2-predominant inflammation and blockade of IFN-gamma signaling induce aneurysms in allografted aortas. J Clin Invest 2004;114(2):300–308.
Carmeliet P, Moons L, Lijnen R, et al. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat Genet 1997;17(4):439–444.
Silence J, Collen D, Lijnen HR. Reduced atherosclerotic plaque but enhanced aneurysm formation in mice with inactivation of the tissue inhibitor of metal-loproteinase-1 (TIMP-1) gene. Circ Res 2002;90(8):897–903.
Sukhova GK, Wang B, Libby P, et al. Cystatin C deficiency increases elastic lamina degradation and aortic dilatation in apolipoprotein E-null mice. Circ Res 2005;96(3):368–375.
Daugherty A, Manning MW, Cassis LA. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 2000;105(11):1605–1612.
Pyo R, Lee JK, Shipley JM, et al. Targeted gene disruption of matrix metallo-proteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest 2000;105(11):1641–1649.
Chen J, Kuhlencordt PJ, Astern J, Gyurko R, Huang PL. Hypertension does not account for the accelerated atherosclerosis and development of aneurysms in male apolipoprotein e/endothelial nitric oxide synthase double knockout mice. Circulation 2001;104(20):2391–2394.
Lee JK, Borhani M, Ennis TL, Upchurch GR, Jr., Thompson RW. Experimental abdominal aortic aneurysms in mice lacking expression of inducible nitric oxide synthase. Arterioscler Thromb Vasc Biol 2001;21(9):1393–1401.
Longo GM, Xiong W, Greiner TC, Zhao Y, Fiotti N, Baxter BT. Matrix metal-loproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest 2002;110(5):625–632.
Bruemmer D, Collins AR, Noh G, et al. Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice. J Clin Invest 2003;112(9):1318–1331.
Deng GG, Martin-McNulty B, Sukovich DA, et al. Urokinase-type plasminogen activator plays a critical role in angiotensin II-induced abdominal aortic aneurysm. Circ Res 2003;92(5):510–517.
Ishibashi M, Egashira K, Zhao Q, et al. Bone marrow-derived monocyte chemoattractant protein-1 receptor CCR2 is critical in angiotensin II-induced acceleration of atherosclerosis and aneurysm formation in hypercholesterolemic mice. Arterioscler Thromb Vasc Biol 2004;24(11):e174–178.
Xiong W, Zhao Y, Prall A, Greiner TC, Baxter BT. Key roles of CD4 + T cells and IFN-gamma in the development of abdominal aortic aneurysms in a murine model. J Immunol 2004;172(4):2607–2612.
Zhao L, Moos MP, Grabner R, et al. The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm. Nat Med 2004;10(9): 966–973.
Eskandari MK, Vijungco JD, Flores A, Borensztajn J, Shively V, Pearce WH. Enhanced abdominal aortic aneurysm in TIMP-1-deficient mice. J Surg Res 2005;123(2):289–293.
Hannawa KK, Eliason JL, Woodrum DT, et al. L-selectin-mediated neu-trophil recruitment in experimental rodent aneurysm formation. Circulation 2005;112(2):241–247.
Longo GM, Buda SJ, Fiotta N, et al. MMP-12 has a role in abdominal aortic aneurysms in mice. Surgery 2005;137(4):457–462.
Thomas M, Gavrila D, McCormick ML, et al. Deletion of p47phox attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice. Circulation 2006;114(5):404–413.
Xiong W, Knispel R, Mactaggart J, Baxter BT. Effects of tissue inhibitor of metalloproteinase 2 deficiency on aneurysm formation. J Vasc Surg 2006;44(5): 1061–1066.
Ahluwalia N, Lin AY, Tager AM, et al. Inhibited aortic aneurysm formation in BLT1-deficient mice. J Immunol 2007;179(1):691–697.
Cao RY, Adams MA, Habenicht AJ, Funk CD. Angiotensin II-induced abdominal aortic aneurysm occurs independently of the 5-lipoxygenase pathway in apolipo-protein E-deficient mice. Prostaglandins Other Lipid Mediat 2007;84(1–2):34–42.
Cassis LA, Rateri DL, Lu H, Daugherty A. Bone marrow transplantation reveals that recipient AT1a receptors are required to initiate angiotensin II-induced atherosclerosis and aneurysms. Arterioscler Thromb Vasc Biol 2007;27(2):380–386.
Gitlin JM, Trivedi DB, Langenbach R, Loftin CD. Genetic deficiency of cycloox-ygenase-2 attenuates abdominal aortic aneurysm formation in mice. Cardiovasc Res 2007;73(1):227–236.
MacTaggart JN, Xiong W, Knispel R, Baxter BT. Deletion of CCR2 but not CCR5 or CXCR3 inhibits aortic aneurysm formation. Surgery 2007;142(2):284–288.
Pagano MB, Bartoli MA, Ennis TL, et al. Critical role of dipeptidyl peptidase I in neutrophil recruitment during the development of experimental abdominal aortic aneurysms. Proc Natl Acad Sci U S A 2007;104(8):2855–2860.
Sun J, Sukhova GK, Yang M, et al. Mast cells modulate the pathogenesis of elastase-induced abdominal aortic aneurysms in mice. J Clin Invest 2007;117(11): 3359–3368.
Tromp G, Wu Y, Prockop DJ, et al. Sequencing of cDNA from 50 unrelated patients reveals that mutations in the triple-helical domain of type III procollagen are an infrequent cause of aortic aneurysms. J Clin Invest 1993;91(6):2539–2545.
Acknowledgments
The authors thank Dr. Gerard Tromp for preparing Fig. 1. The original work carried out in the Kuivaniemi laboratory was funded in part by the National Heart, Lung, and Blood Institute of the NIH (HL045996 and HL06410 to H.K.). J.H.L. is a recipient of a Predoctoral Fellowship from the National Institute on Aging, NIH (AG030900), and G.M.L. is a recipient of a Predoctoral Fellowship from the American Heart Association (0510063Z and 0710099Z).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Lillvis, J.H., Lenk, G.M., Kuivaniemi, H. (2009). Genetics of Abdominal Aortic Aneurysms. In: Upchurch, G.R., Criado, E. (eds) Aortic Aneurysms. Contemporary Cardiology. Humana Press. https://doi.org/10.1007/978-1-60327-204-9_1
Download citation
DOI: https://doi.org/10.1007/978-1-60327-204-9_1
Publisher Name: Humana Press
Print ISBN: 978-1-60327-203-2
Online ISBN: 978-1-60327-204-9
eBook Packages: MedicineMedicine (R0)